HIGHLIGHTS
- who: Jason L. Jia et al. from the Core Internal Medicine Residency Program, Department of Medicine, University of Ottawa, Ottawa, ON K H , Canada have published the article: Temozolomide Chronotherapy in Glioma: A Systematic Review, in the Journal: (JOURNAL) of 30/08/2022
- future: While the authors wait for more novel and effective therapies a more pragmatic approach to optimizing TMZ in GBM needs to be explored.
SUMMARY
The current standard of treatment for newly diagnosed GBM was established in 2005, whereby the addition of TMZ to post-operative radiation demonstrated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.